Correlation Between Chroma ATE and Handa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chroma ATE and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chroma ATE and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chroma ATE and Handa Pharmaceuticals, you can compare the effects of market volatilities on Chroma ATE and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chroma ATE with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chroma ATE and Handa Pharmaceuticals.

Diversification Opportunities for Chroma ATE and Handa Pharmaceuticals

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Chroma and Handa is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Chroma ATE and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Chroma ATE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chroma ATE are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Chroma ATE i.e., Chroma ATE and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Chroma ATE and Handa Pharmaceuticals

Assuming the 90 days trading horizon Chroma ATE is expected to generate 0.85 times more return on investment than Handa Pharmaceuticals. However, Chroma ATE is 1.18 times less risky than Handa Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  17,750  in Chroma ATE on August 30, 2024 and sell it today you would earn a total of  22,950  from holding Chroma ATE or generate 129.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.79%
ValuesDaily Returns

Chroma ATE  vs.  Handa Pharmaceuticals

 Performance 
       Timeline  
Chroma ATE 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chroma ATE are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Chroma ATE showed solid returns over the last few months and may actually be approaching a breakup point.
Handa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Chroma ATE and Handa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chroma ATE and Handa Pharmaceuticals

The main advantage of trading using opposite Chroma ATE and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chroma ATE position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.
The idea behind Chroma ATE and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Correlations
Find global opportunities by holding instruments from different markets